636 related articles for article (PubMed ID: 19910459)
1. Cannabinoids Delta(9)-tetrahydrocannabinol and cannabidiol differentially inhibit the lipopolysaccharide-activated NF-kappaB and interferon-beta/STAT proinflammatory pathways in BV-2 microglial cells.
Kozela E; Pietr M; Juknat A; Rimmerman N; Levy R; Vogel Z
J Biol Chem; 2010 Jan; 285(3):1616-26. PubMed ID: 19910459
[TBL] [Abstract][Full Text] [Related]
2. miRNA expression profiles and molecular networks in resting and LPS-activated BV-2 microglia-Effect of cannabinoids.
Juknat A; Gao F; Coppola G; Vogel Z; Kozela E
PLoS One; 2019; 14(2):e0212039. PubMed ID: 30742662
[TBL] [Abstract][Full Text] [Related]
3. Cannabinoids Alleviate the LPS-Induced Cytokine Storm via Attenuating NLRP3 Inflammasome Signaling and TYK2-Mediated STAT3 Signaling Pathways In Vitro.
Suryavanshi SV; Zaiachuk M; Pryimak N; Kovalchuk I; Kovalchuk O
Cells; 2022 Apr; 11(9):. PubMed ID: 35563697
[TBL] [Abstract][Full Text] [Related]
4. Microarray and pathway analysis reveal distinct mechanisms underlying cannabinoid-mediated modulation of LPS-induced activation of BV-2 microglial cells.
Juknat A; Pietr M; Kozela E; Rimmerman N; Levy R; Gao F; Coppola G; Geschwind D; Vogel Z
PLoS One; 2013; 8(4):e61462. PubMed ID: 23637839
[TBL] [Abstract][Full Text] [Related]
5. Differential transcriptional profiles mediated by exposure to the cannabinoids cannabidiol and Δ9-tetrahydrocannabinol in BV-2 microglial cells.
Juknat A; Pietr M; Kozela E; Rimmerman N; Levy R; Coppola G; Geschwind D; Vogel Z
Br J Pharmacol; 2012 Apr; 165(8):2512-28. PubMed ID: 21542829
[TBL] [Abstract][Full Text] [Related]
6. Receptor-mediated effects of Δ
Preteroti MW; Traboulsi H; Greiss P; Lapohos O; Fonseca GJ; Eidelman DH; Baglole CJ
Immunol Cell Biol; 2023 Feb; 101(2):156-170. PubMed ID: 36510483
[TBL] [Abstract][Full Text] [Related]
7. The non-psychoactive plant cannabinoid, cannabidiol affects cholesterol metabolism-related genes in microglial cells.
Rimmerman N; Juknat A; Kozela E; Levy R; Bradshaw HB; Vogel Z
Cell Mol Neurobiol; 2011 Aug; 31(6):921-30. PubMed ID: 21533611
[TBL] [Abstract][Full Text] [Related]
8. Cannabidiol prevents LPS-induced microglial inflammation by inhibiting ROS/NF-κB-dependent signaling and glucose consumption.
Dos-Santos-Pereira M; Guimarães FS; Del-Bel E; Raisman-Vozari R; Michel PP
Glia; 2020 Mar; 68(3):561-573. PubMed ID: 31647138
[TBL] [Abstract][Full Text] [Related]
9. MyD88-dependent and -independent signalling via TLR3 and TLR4 are differentially modulated by Δ
Fitzpatrick JM; Minogue E; Curham L; Tyrrell H; Gavigan P; Hind W; Downer EJ
J Neuroimmunol; 2020 Jun; 343():577217. PubMed ID: 32244040
[TBL] [Abstract][Full Text] [Related]
10. Botanically-Derived Δ
Fitzpatrick JM; Hackett B; Costelloe L; Hind W; Downer EJ
Molecules; 2022 Mar; 27(6):. PubMed ID: 35335126
[TBL] [Abstract][Full Text] [Related]
11. Cannabinoid effects on β amyloid fibril and aggregate formation, neuronal and microglial-activated neurotoxicity in vitro.
Janefjord E; Mååg JL; Harvey BS; Smid SD
Cell Mol Neurobiol; 2014 Jan; 34(1):31-42. PubMed ID: 24030360
[TBL] [Abstract][Full Text] [Related]
12. Cannabidiol affects the expression of genes involved in zinc homeostasis in BV-2 microglial cells.
Juknat A; Rimmerman N; Levy R; Vogel Z; Kozela E
Neurochem Int; 2012 Nov; 61(6):923-30. PubMed ID: 22178458
[TBL] [Abstract][Full Text] [Related]
13. Combination of cannabinoids, delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), mitigates experimental autoimmune encephalomyelitis (EAE) by altering the gut microbiome.
Al-Ghezi ZZ; Busbee PB; Alghetaa H; Nagarkatti PS; Nagarkatti M
Brain Behav Immun; 2019 Nov; 82():25-35. PubMed ID: 31356922
[TBL] [Abstract][Full Text] [Related]
14. Cannabinoid receptor expression in non-small cell lung cancer. Effectiveness of tetrahydrocannabinol and cannabidiol inhibiting cell proliferation and epithelial-mesenchymal transition in vitro.
Milian L; Mata M; Alcacer J; Oliver M; Sancho-Tello M; Martín de Llano JJ; Camps C; Galbis J; Carretero J; Carda C
PLoS One; 2020; 15(2):e0228909. PubMed ID: 32049991
[TBL] [Abstract][Full Text] [Related]
15. Cannabinoids Δ
Majdi F; Taheri F; Salehi P; Motaghinejad M; Safari S
Med Hypotheses; 2019 Dec; 133():109371. PubMed ID: 31465975
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of an equilibrative nucleoside transporter by cannabidiol: a mechanism of cannabinoid immunosuppression.
Carrier EJ; Auchampach JA; Hillard CJ
Proc Natl Acad Sci U S A; 2006 May; 103(20):7895-900. PubMed ID: 16672367
[TBL] [Abstract][Full Text] [Related]
17. Cannabinoids decrease the th17 inflammatory autoimmune phenotype.
Kozela E; Juknat A; Kaushansky N; Rimmerman N; Ben-Nun A; Vogel Z
J Neuroimmune Pharmacol; 2013 Dec; 8(5):1265-76. PubMed ID: 23892791
[TBL] [Abstract][Full Text] [Related]
18. Abnormal Cannabidiol Affects Production of Pro-Inflammatory Mediators and Astrocyte Wound Closure in Primary Astrocytic-Microglial Cocultures.
Cardinal von Widdern J; Hohmann T; Dehghani F
Molecules; 2020 Jan; 25(3):. PubMed ID: 31979350
[TBL] [Abstract][Full Text] [Related]
19. Anti-inflammatory effects of the cannabidiol derivative dimethylheptyl-cannabidiol - studies in BV-2 microglia and encephalitogenic T cells.
Juknat A; Kozela E; Kaushansky N; Mechoulam R; Vogel Z
J Basic Clin Physiol Pharmacol; 2016 May; 27(3):289-96. PubMed ID: 26540221
[TBL] [Abstract][Full Text] [Related]
20. Cannabidiol prevents LPS-induced inflammation by inhibiting the NLRP3 inflammasome and iNOS activity in BV2 microglia cells via CB2 receptors and PPARγ.
Rodrigues FDS; Newton WR; Tassinari ID; da Cunha Xavier FH; Marx A; de Fraga LS; Wright K; Guedes RP; Bambini-Jr V
Neurochem Int; 2024 Jul; 177():105769. PubMed ID: 38761855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
